Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Multiomics Services Market Growth Potential: How Will Market Size Change Through 2030?
The market for multiomics services has experienced substantial expansion lately. Projections indicate a rise from $1.42 billion in 2025 to $1.71 billion by 2026, reflecting a 20.4% compound annual growth rate (CAGR). This notable growth during the preceding period is linked to increased genomic and proteomic research endeavors, augmented funding for academic and clinical studies, greater accessibility of advanced sequencing technologies, enhanced collaborations among research bodies, and bolstered bioinformatics capabilities.
The global market for multiomics services is poised for substantial expansion, projected to reach $3.56 billion by 2030, demonstrating a robust compound annual growth rate of 20.1%. This upward trajectory is propelled by several key factors, including the escalating embrace of precision medicine, augmented investments by pharmaceutical companies in systems biology research, broader utility of multiomics in drug discovery endeavors, a surge in the application of artificial intelligence for interpreting biological data, and a heightened need for bespoke therapeutic strategies. During this anticipated growth phase, significant trends are expected to emerge, such as a greater uptake of unified multiomics analytical platforms, increasing demand for single-cell multiomics capabilities, a more pronounced reliance on insights derived from data-driven biological studies, the proliferation of cloud-based solutions for omics data integration, and an intensified emphasis on applications within translational research.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27355&type=smp
Multiomics Services Market Expansion Supported By Key Demand Factors
The expansion of the multiomics services sector is anticipated to be significantly fueled by the growing trend towards personalized medicine. This approach to healthcare focuses on customizing interventions and medical strategies based on an individual’s genetic makeup and environmental influences. A key driver for this shift is the growing population seeking health solutions that provide continuous monitoring and treatment pathways specifically adapted to their individual biological characteristics. Multiomics services are instrumental in furthering personalized medicine by consolidating a wide array of biological data, including information from genomics, transcriptomics, proteomics, and metabolomics, to cultivate a holistic view of an individual’s health status. This integrated analysis facilitates the development of precise diagnostic, therapeutic, and preventative measures. For example, the Personalized Medicine Coalition (PMC) reported in February 2024 that the U.S. Food and Drug Administration (FDA) authorized 26 novel personalized medicines in 2023, a notable surge compared to the 12 approvals granted in 2022, underscoring the substantial growth in this area and its consequential positive impact on the multiomics services market.
Multiomics Services Market Segments: Where Are The Largest Growth Opportunities?
The multiomics services market covered in this report is segmented –
1) By Type: Single-Cell Multiomics, Bulk Multiomics
2) By Application: Biomarker Discovery, Drug Discovery And Development, Synthetic Biology, Other Applications
3) By End Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Single-Cell Multiomics: Single-Cell Genomics Services, Single-Cell Transcriptomics Services, Single-Cell Proteomics Services, Single-Cell Epigenomics Services
2) By Bulk Multiomics: Genomics And Transcriptomics Integration Services, Genomics And Proteomics Integration Services, Transcriptomics And Proteomics Integration Services, Epigenomics And Transcriptomics Integration Services
Multiomics Services Market Growth Trends Influencing Competitive Dynamics
Leading entities within the multiomics services sector are dedicating efforts to pioneering novel methodologies, like intricate 3D genome mapping, with the aim of deepening comprehension of genetic control, the underlying causes of illnesses, and tailored therapeutic interventions. This sophisticated 3D genome mapping technique involves charting the spatial arrangement of the genome in three dimensions inside a cell’s nucleus. As a prime example, in January 2025, Enhanc3D Genomics, a biotechnology firm situated in the UK, introduced a comprehensive set of 3D multi-omics solutions designed to expedite and refine the accuracy of drug discovery processes. This offering boasts distinctive capabilities, including the amalgamation of regulatory interaction data across the entire genome with multi-omics profiles within a solitary test, thereby facilitating profound insights into gene regulation. Their proprietary Promoter Capture Hi-C technology permits the exact charting of extensive interactions between regulatory elements and their corresponding genes, even encompassing regions outside of protein-coding areas. The platform’s adaptable framework, comprising GenLinkConnect, GenLinkResponse, and GenLinkProfile, correspondingly aids in linking single nucleotide polymorphisms to genes, analyzing drug responses, and profiling cell-specific regulatory mechanisms. Furthermore, the GenLinkHub software furnishes a user-friendly interface for visualizing data in three dimensions, managing vast datasets, and performing quality assessments, thereby boosting researchers’ capacity to interpret intricate information and accelerate the discovery of new medications.
Multiomics Services Market Major Participants And Competitive Dynamics
Major companies operating in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., Clinical Microbiomics A/S.
Access The Complete Multiomics Services Market Report:
https://www.thebusinessresearchcompany.com/report/multiomics-services-global-market-report
Multiomics Services Market Regional Analysis: Which Region Leads By Revenue?
North Americawas the largest region in the multiomics services market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
